Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matcheri S Keshavan, M.D.

Co-Author

This page shows the publications co-authored by Matcheri Keshavan and Luis Sandoval.
Connection Strength

1.921
  1. Effects of peer social interaction on performance during computerized cognitive remediation therapy in patients with early course schizophrenia: A pilot study. Schizophr Res. 2019 01; 203:17-23.
    View in: PubMed
    Score: 0.745
  2. Smartphones for Smarter Care? Self-Management in Schizophrenia. Am J Psychiatry. 2017 08 01; 174(8):725-728.
    View in: PubMed
    Score: 0.740
  3. Characterizing Smartphone Engagement for Schizophrenia: Results of a Naturalist Mobile Health Study. Clin Schizophr Relat Psychoses. 2017 Aug 04.
    View in: PubMed
    Score: 0.185
  4. Confirmatory Efficacy of Cognitive Enhancement Therapy for Early Schizophrenia: Results From a Multisite Randomized Trial. Psychiatr Serv. 2021 Sep 02; appips202000552.
    View in: PubMed
    Score: 0.061
  5. Characterizing the clinical relevance of digital phenotyping data quality with applications to a cohort with schizophrenia. NPJ Digit Med. 2018; 1:15.
    View in: PubMed
    Score: 0.048
  6. Relapse prediction in schizophrenia through digital phenotyping: a pilot study. Neuropsychopharmacology. 2018 07; 43(8):1660-1666.
    View in: PubMed
    Score: 0.048
  7. A comparison of passive and active estimates of sleep in a cohort with schizophrenia. NPJ Schizophr. 2017 Oct 16; 3(1):37.
    View in: PubMed
    Score: 0.047
  8. A comparison of passive and active estimates of sleep in a cohort with schizophrenia. NPJ Schizophr. 2017; 3:37.
    View in: PubMed
    Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.